考虑口服避孕药(OC)与糖尿病的关系提示了两大问题:第一、OC是否增加了发生糖尿病的危险。第二、对已确诊的糖尿病人是否适用这些OC制剂。 雌激素—孕激素类的OC对碳水化合物及脂肪代谢的影响已有广泛研究。已确定这一类中的许多制可以引起一定的代谢障碍。由于多数研究对各种不同的制剂未曾明确区分,因而关于OC对代谢的影响至今尚存在着许多混乱.Wynn等最近才较好的澄清了这种情况。他们认为含有大于50微克雌 Considering the relationship between oral contraceptives (OC) and diabetes suggests two major questions: first, is OC increasing the risk of developing diabetes? Second, whether or not these OC preparations are applied to diagnosed diabetics. The effects of estrogen-progestin OCs on carbohydrate and fat metabolism have been extensively studied. Many systems in this category have been identified as causing certain metabolic disorders. As most studies have not clearly distinguished between different agents, so far there has been a lot of confusion about the effects of OC on metabolism, as Wynn et al. Have recently clarified. They think they contain more than 50 micrograms of female